ANCN

Anchiano Therapeutics Ltd

NASDAQ

Add Alert

ANCN

Anchiano Therapeutics Ltd

NASDAQ

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

dinogreeves PremiumMember

03/16/21 7:49 PM

Post #28

ANCN will hit 12-15 tomorrow. Good luck.

ClayTrader Free

03/16/21 5:55 PM

Post #27

* * $ANCN Video Chart 03-16-2021 * *

Link to Video - click here to watch the technical chart video

Jconwon

03/08/21 6:32 PM

Post #26

Opened at 5.60 and pushed past and then rejected. Re-test of the 5.60 after pullback to 6.75. 22% I guess those longer wicks dont matter the later the day?

ClayTrader Free

03/08/21 4:58 PM

Post #25

* * $ANCN Video Chart 03-08-2021 * *

Link to Video - click here to watch the technical chart video

ClayTrader Free

02/10/21 5:59 PM

Post #24

* * $ANCN Video Chart 02-10-2021 * *

Link to Video - click here to watch the technical chart video

ClayTrader Free

12/15/20 4:06 PM

Post #23

* * $ANCN Video Chart 12-15-2020 * *

Link to Video - click here to watch the technical chart video

Cubanwinner Free

12/15/20 11:32 AM

Post #22

Re: #21: @Jess070283 - Show me the money!$$$$ Patience pays off!!!!

Patience for all who buy weeks and weeks ago!!!
CONGRATULATIONS ALL BAG HOLDERS!!

Jess070283 Free

12/15/20 10:38 AM

Post #21

Show me the money!$$$$ Patience pays off!!!!

Flanker7

11/19/20 12:02 PM

Post #20

Re: #19: @sanderburwil - New CEO- Russian money backing this- mega merger

Higher lows creating bullish ascending triangle, any mouse squeak of news or PR might skyrocket this low floater...again

sanderburwil Free

11/10/20 12:22 PM

Post #19

New CEO- Russian money backing this- mega merger

sanderburwil Free

11/10/20 6:04 AM

Post #18

Re: #17: @Flanker7 - Chart and L2looking interesting again

Something sure is cooking

Flanker7

11/09/20 10:55 AM

Post #17

Chart and L2looking interesting again

Jess070283 Free

11/06/20 7:21 PM

Post #16

Pump it up!$$$

Jess070283 Free

11/05/20 4:05 PM

Post #15

Loading this dip!$$$$

Timing101

10/21/20 12:10 PM

Post #14

ANCN... shorters.. they will have to cover

Timing101

10/20/20 8:11 PM

Post #13

New CEO Neil Cohen... maker and shaker of companies.. all good
--
Appointment of Neil Cohen as CEO

On October 20, 2020, Anchiano Therapeutics Ltd. (the “Company”) appointed Neil Cohen, age 57, as Chief Executive Officer of the Company, effective immediately. Pursuant to his employment agreement, in his capacity as Chief Executive Officer of the Company Mr. Cohen will receive a gross salary of $12,000 per month. Mr. Cohen will continue to serve as a member of the Company’s board of directors (the “Board”).

Mr. Cohen has served as the Chairman and Chief Executive Officer of Castel Partners Ltd. since January 2012. In 1994, he co-founded Israel Seed Partners, a leading venture capital firm, and managed the firm until 2019. Mr. Cohen has invested in and served on the boards of directors of many private technology companies, including a large number which were acquired or completed successful initial public offerings, including Compugen (Nasdaq: CGEN), Shopping.com (Nasdaq: SHOP, acquired by EBAY), Broadlight (acquired by Broadcom, Nasdaq: AVGO) and Cyota (acquired by RSA). He is a venture partner at SKY, an Israeli middle-market private equity firm, at Hetz Ventures Management Ltd., an early-stage Israeli venture capital fund, and Shavit Capital. Mr. Cohen was previously the Business Editor of The Jerusalem Post and began his career in the private equity group at the Rothschild Bioscience Unit of N M Rothschild & Sons Limited in London. Mr. Cohen received a B.A. and M.A., with first class honors, from Oxford University.

Mr. Cohen is not a party to any agreement or transaction that would require disclosure under Item 404(a) of Regulation S-K. There are no family relationships between Mr. Cohen and any other director or executive officer of the Company that would require disclosure under Items 401(d) or 404(a) of Regulation S-K.

Timing101

10/20/20 6:39 PM

Post #12

$ANCN... on many watch lists for Wed.. EP's Entry Point, Exit Point
and RE.. Re Entry today was huge.
--
Nice
--
8-K new CEO .. proven track record
$ANCN... 8-kFiled today after close... keep this on watch for WED Market.
https://www.otcmarkets.com/filing/html?id=14449576&guid=fZ_eU6LweVbdW3h

otcmoneydoubler Free

10/20/20 5:20 PM

Post #11

Re: #10: @Flanker7 - 8K out http://archive.fast-edgar.com/20201020/A9BZV22D8C22U9ZU222T2ZZZB22DZ2Q2ZV

GREAT NEWS. ANCN SHOULD BE A GOOD WATCH FOR TONIGHT AND TOMORROW. GONE FOR THE NIGHT, WEI HAS MADE MY DAY.

Flanker7

10/20/20 4:02 PM

Post #10

8K out http://archive.fast-edgar.com/20201020/A9BZV22D8C22U9ZU222T2ZZZB22DZ2Q2ZV22/

Timing101

10/20/20 2:02 PM

Post #9

yep ... volume today ...

Flanker7

10/20/20 12:25 PM

Post #8

Juuuust a bit of volume today smile

swingingRichard Free

07/21/20 10:54 PM

Post #7

0210

07/18/20 9:08 AM

Post #6

Re: #3: @FreeBird - Looking into this, what's your speculation? Unbelievable drop

Nice pop to 0.96...looks "similiar" drop with cbl 52-wk low @0.18 yesterday. trade opp ahead...IF not, let's see what ANCN's new mgt got.

0210

07/18/20 8:59 AM

Post #4

Re: #3: @FreeBird - Looking into this, what's your speculation? Unbelievable drop

Trade opp ahead...let's see what ANCN's new mgt got.

FreeBird

07/15/20 12:12 PM

Post #3

Re: #2: @0210 - 80s - hi 70s. MC $30m 50% cash, hmmmm...

Looking into this, what's your speculation?
Unbelievable drop

0210

07/14/20 10:14 AM

Post #2

80s - hi 70s. MC $30m 50% cash, hmmmm...

0210

06/10/20 7:05 AM

Post #1

A/S 100m O/S 37.1m Mkt Cap: $50m. Nasdaq IPO: $11.50 on 02/2019.

Anchiano Therapeutics Ltd (ANCN)

Followers	1	Posters	12
Posts (Today)	0	Posts (Total)	28
Created	06/10/20	Type	Free
Moderators

Anchiano Therapeutics Ltd. is a clinical-stage biopharmaceutical company, which engages in tin the discovery, development and commercialization of drugs for cancer-related diseases.

Due Diligence: ANCN